Home › Oropharyngeal Cancer › Georgia
Oropharyngeal Cancer clinical trials in Georgia
8 studies for Oropharyngeal Cancer are looking for participants at sites in Georgia.
Cities in Georgia
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
- Emory Proton Therapy Center, Atlanta
- Emory University Hospital Midtown, Atlanta
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07195734Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
- Emory University Hospital Midtown, Atlanta
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06254911Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Winship Cancer Institute - Emory University, Atlanta
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 29, 2026 · NCT04198766Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
- Emory Midtown University Hospital/Winship Cancer Institute, Atlanta
Recruiting
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT06662058SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
- Emory University Hospital Midtown, Atlanta
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT05451004TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Mar 4, 2026 · NCT06868433Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 11, 2026 · NCT06636734Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
- Emory University Hospital Midtown, Atlanta
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Oct 22, 2025 · NCT06914999From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.